Insights from Multi-Omics on Maternal-Fetal Immune Tolerance in Recurrent Pregnancy Loss: Mechanisms, Integration Challenges, and Clinical Implications - Takeaways - MDSpire

Insights from Multi-Omics on Maternal-Fetal Immune Tolerance in Recurrent Pregnancy Loss: Mechanisms, Integration Challenges, and Clinical Implications

  • By

  • Mengqiu Shao

  • Yiting Zhang

  • Haixia Tang

  • Ze Zhou

  • Manyin Zhai

  • Xiaoyu Zhou

  • Xiaoyu Bi

  • Jiabao Liao

  • Caiyan Zhang

  • Lijuan Jiang

  • April 29, 2026

  • 0 min

Share

  • 1

    Recurrent pregnancy loss (RPL) affects 1% to 5% of women and is defined variably by different professional guidelines.

  • 2

    Multi-omics profiling is essential for understanding the complex mechanisms underlying RPL and for biomarker discovery.

  • 3

    Genomic and epigenomic studies reveal chromosomal abnormalities and aberrant methylation patterns linked to RPL.

  • 4

    Integration of multi-omics data with computational frameworks can enhance RPL subtype classification and risk prediction.

  • 5

    Future research should focus on standardized multi-omics approaches to improve the clinical relevance of RPL studies.

Original Source(s)

Insights from Multi-Omics on Maternal-Fetal Immune Tolerance in Recurrent Pregnancy Loss: Mechanisms, Integration Challenges, and Clinical Implications

  • by Mengqiu Shao, Yiting Zhang, Haixia Tang, Ze Zhou, Manyin Zhai, Xiaoyu Zhou, Xiaoyu Bi, Jiabao Liao, Caiyan Zhang, Lijuan Jiang

  • April 29, 2026

Related Content

Innovative approaches for induction of gastrointestinal anastomotic healing: an update on experimental and clinical aspects

From bugs to brain: unravelling the GABA signalling networks in the brain–gut–microbiome axis

Oxidized Polyunsaturated Fatty Acid Promotes Colitis and Colitis-Associated Tumorigenesis in Mice